Cargando…
Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis
BACKGROUND: Diabetes mellitus is an independent risk factor of increased morbidity and mortality in patients with heart failure. Cardiac resynchronization therapy (CRT), a pacemaker-based therapy for dyssynchronous heart failure, improves cardiac performance and quality of life, but its effect on mo...
Autores principales: | Sun, Hui, Guan, Yuqing, Wang, Lei, Zhao, Yong, Lv, Hong, Bi, Xiuping, Wang, Huating, Zhang, Xuejing, Liu, Li, Wei, Min, Song, Hui, Su, Guohai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461910/ https://www.ncbi.nlm.nih.gov/pubmed/25880202 http://dx.doi.org/10.1186/s12872-015-0018-0 |
Ejemplares similares
-
Outcomes of Cardiac Resynchronization Therapy in Patients with Hypothyroidism and Heart Failure
por: Yang, Mei, et al.
Publicado: (2020) -
The impact of gender difference on clinical and echocardiographic outcomes in patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis
por: Yin, Fa-Hui, et al.
Publicado: (2017) -
Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
por: Gasparini, Maurizio, et al.
Publicado: (2009) -
Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure
por: Osmanska, Joanna, et al.
Publicado: (2018) -
Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy
por: Beca, Bogdan, et al.
Publicado: (2019)